Funds · BIS

Who owns BIS?

No institutional manager reported a ProShares UltraShort Nasdaq Biotechnology position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

BIS news and filings · Top funds